Hello Tomorrow
Xavier Duportet is the co-founder & CEO at Eligo Bioscience, pioneering first-in-class in vivo CRISPR & gene editing modalities to address serious diseases in immuno-inflammation & oncology. Xavier is also the co-founder and President at Deeptech Founders, a startup acceleration program for entrepreneurial scientists. Xavier is a member of the Strategic Advisory Board at Université Paris-Saclay and Universcience, as well as a Senior Advisor at the French Ministry of Foreign Affairs & Ministry of Economy, Finance and Industry. With a background in Synthetic Biology and Molecular Biology, Xavier has been involved in a variety of innovative projects and ventures, bridging the gap between science and business to address pressing global issues.
This person is not in the org chart
Hello Tomorrow
1 followers
Hello Tomorrow was created in 2011 by a group of individuals convinced that science and technology need to form part of a toolkit of solutions to change our industries, sustain a growing population and help solve global crises. But the traditional model of technology transfer to bring solutions from lab to market, and from idea to impact, could not rise to this challenge. In turn, Hello Tomorrow has built, and now animates, a global ecosystem that facilitates ‘deep tech’ innovation through multiple activities. Over the course of nine editions, their Global Startup Challenge has received 30,000 applications from 132 countries, partnering with universities and research institutions worldwide to identify deep tech solutions that have real global impact. Hello Tomorrow then uses its unique position to identify and analyze deep tech trends and dynamics. Through their international events, they connect all key players to harness their full potential. Through consulting services in strategy and innovation and customised startups programs, they help companies to understand how deep tech will impact their business, how to stay competitive and launch new solutions.